151 related articles for article (PubMed ID: 35610463)
1. Fixed-dose aspirin monotherapy compared with thromboelastography directed antiplatelet therapy in long-term management of left ventricular assist devices.
Fanelli SJ; Elzeneini M; Meece LE; Mahmoud A; Jeng EI; Harris N; Ahmed MM
J Card Surg; 2022 Sep; 37(9):2621-2628. PubMed ID: 35610463
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
4. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.
Majeed F; Kop WJ; Poston RS; Kallam S; Mehra MR
Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):147-57. PubMed ID: 19174824
[TBL] [Abstract][Full Text] [Related]
5. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
Baumann Kreuziger LM; Kim B; Wieselthaler GM
J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
[TBL] [Abstract][Full Text] [Related]
8. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
Trials; 2012 Apr; 13():48. PubMed ID: 22540524
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system.
Attisani M; Centofanti P; La Torre M; Campanella A; Sansone F; Rinaldi M
J Artif Organs; 2010 Dec; 13(4):202-6. PubMed ID: 21127929
[TBL] [Abstract][Full Text] [Related]
11. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
12. Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study.
Volod O; Lam LD; Lin G; Kam C; Kolyouthapong K; Mac J; Mirocha J; Ambrose PJ; Czer LS; Arabia FA
ASAIO J; 2017; 63(1):24-31. PubMed ID: 27660902
[TBL] [Abstract][Full Text] [Related]
13. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
16. Triple Antithrombotic Therapy in Patients With Left Ventricular Assist Devices.
Krim SR; Bennett A; Pfeffer M; Campbell PT; Thai S; Baetz B; Wever-Pinzon J; Eiswirth C; Desai S; Ventura HO
Curr Probl Cardiol; 2022 Aug; 47(8):100940. PubMed ID: 34384617
[TBL] [Abstract][Full Text] [Related]
17. Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices.
Baumann Kreuziger LM
J Thromb Thrombolysis; 2015 Apr; 39(3):337-44. PubMed ID: 25549823
[TBL] [Abstract][Full Text] [Related]
18. Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.
Karimi A; Beaver TM; Hess PJ; Martin TD; Staples ED; Schofield RS; Hill JA; Aranda JM; Klodell CT
Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):457-65. PubMed ID: 24421208
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
[TBL] [Abstract][Full Text] [Related]
20. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
